BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Annexin A2 (ANXA2); semaphorin 3D (SEMA3D)

September 17, 2015 7:00 AM UTC

In vitro and mouse studies suggest inhibiting ANXA2 or SEMA3D could help treat metastatic pancreatic ductal adenocarcinoma (PDAC). In human PDAC samples, high SEMA3D levels were associated with early ...